Bridge to Life Acquires VitaSmart™ Hypothermic Oxygenated Machine Perfusion System from Medica S.p.A.

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

BTL-Acquire-VitaSmart

More Like This

PR Newswire associated0

Bridge to Life Ltd. Achieves Global Milestone Using Hypothermic Oxygenated Perfusion (HOPE) and VitaSmart™ System

PR Newswire associated0

Landmark Study Published in the Journal of the American Medical Association (JAMA) Surgery Validates Bridge to Life's VitaSmart™ HOPE Perfusion System as a Superior Organ Preservation Technology

PR Newswire associated0

Bridge to Life™ Secures FDA De Novo Clearance for VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, the First Ever U.S. Approval for Cold Machine Perfusion in Liver Transplant Preservation

PR Newswire associated0

/C O R R E C T I O N -- Bridge to Life, Ltd./

PR Newswire associated0

Bridge to Life Presents New ILTS 2026 Data Showing VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) Expands Use of Marginal Donor Livers and Preserves Mitochondrial Function for Real-Time Viability Assessment

PR Newswire associated0

First-Ever Multicenter Study of Hypothermic Oxygenated Perfusion (HOPE) with VitaSmart™ in Pediatric Liver Transplants Confirms Safety and Favorable Outcomes

PR Newswire associated0

Bridge to Life Achieves ISO 13485:2016 Certification, Reinforcing Commitment to Quality and Safety in Hypothermic Oxygenated Perfusion and Cold Flush Organ Preservation Solutions

PR Newswire associated0

Bridge to Life™ Unveils Groundbreaking 12-Month Clinical Trial Data on HOPE at World Transplant Congress 2025